Philip Morris International (PM) Last Update 3/27/26
Related: CMG KO MCD PEP
% of Stock Price
Revenue
Gross Profits
Free Cash Flow
Philip Morris International
STOCK PRICE
DIVISION
% of STOCK PRICE
Europe
49.4%
$102
Americas
7.9%
$16
Net Debt
13.4% $28
TOTAL
100%
$207
$179.12
Yours
Trefis Price
N/A
$164
Market
 
Top Drivers for Period
Key Drivers
loading revenue data...
loading ebitda data...
loading cash flow data...

RECENT NEWS AND ANALYSIS

Potential upside & downside to trefis price

Philip Morris International Company

VALUATION HIGHLIGHTS

  1. Europe constitutes 49% of the Trefis price estimate for Philip Morris International's stock.
  2. SSEA, CIS & MEA constitutes 25% of the Trefis price estimate for Philip Morris International's stock.
  3. EA, AU & PMI DF constitutes 18% of the Trefis price estimate for Philip Morris International's stock.

WHAT HAS CHANGED?

Latest Earnings: Q4 and Full Year 2025

Philip Morris International reported fourth-quarter 2025 revenue of 10.36 billion dollars, a 6.8% increase year-over-year, with adjusted EPS of 1.70 dollars meeting analyst expectations. For the full year 2025, net revenues reached a record 40.6 billion dollars, up 7.3%, while adjusted diluted EPS grew 14.8% to 7.54 dollars. This performance was anchored by the smoke-free business, which contributed 16.9 billion dollars or 41.5% of total revenue, and continued strength in combustible pricing which offset volume declines in traditional markets.

Note: Philip Morris International's FY'25 ended on December 31, 2025.

National Rollout of IQOS ILUMA in the United States

The company has successfully launched its national expansion of IQOS ILUMA across the United States, representing a critical milestone in its smoke-free transformation. By leveraging the distribution network acquired through Swedish Match, Philip Morris is targeting the high-margin U.S. nicotine market with a phased rollout. This strategic move aims to capture market share from traditional combustibles and established e-vapor competitors, backed by ongoing FDA applications to authorize ZYN and IQOS as modified-risk tobacco products.

POTENTIAL UPSIDE & DOWNSIDE TO TREFIS PRICE

Below are key drivers of Philip Morris International's value that present opportunities for upside or downside to the current Trefis price estimate:

Smoke-Free Products


  • U.S. Nicotine Pouch Momentum: ZYN shipment volumes grew nearly 37% in the U.S. during 2025. If the company achieves the high-single-digit to low-teens growth targets set for 2026-2028 through manufacturing capacity expansion, there is significant upside to current valuation models, though potential FDA marketing restrictions on flavors remain a downside risk.

  • Global IQOS Conversion Rate: With over 43 million adult users at the end of 2025, the conversion of cigarette smokers to heated tobacco remains the primary margin driver. Trefis estimates assume steady user growth; however, a faster-than-expected rollout of the ILUMA induction technology in emerging markets could drive a positive revision in recurring revenue forecasts.

For additional details, select a division from the interactive Trefis split for Philip Morris International at the top of the page.

BUSINESS SUMMARY

Philip Morris International is a global tobacco leader transitioning toward a smoke-free future by replacing cigarettes with scientifically substantiated alternatives like IQOS and ZYN, while maintaining cash-flow stability through its international combustible tobacco business.

SOURCES OF VALUE

The Smoke-Free Products segment has emerged as the most critical source of value due to its superior gross profit margins and high growth potential relative to the declining cigarette industry.

IQOS Category Leadership

Philip Morris holds an estimated 76% volume share of the global heated tobacco category. This dominant position is supported by an industry-leading patent portfolio and a first-mover advantage that creates significant brand loyalty. The recurring nature of the heatstick consumables provides a stable, high-margin revenue stream that mimics the traditional cigarette business model but with favorable excise tax treatment in many jurisdictions.

ZYN and Oral Nicotine Dominance

The acquisition of Swedish Match provided the company with ZYN, the leading brand in the fast-growing modern oral nicotine category. ZYN's approximately 75% market share in the U.S. and its expansion into international markets like Europe and Asia provide a capital-efficient growth lever that complements the company's heated tobacco portfolio.

KEY TRENDS

Regulatory Headwinds in Emerging Markets

The recent ban on heated tobacco products in India represents a significant regulatory challenge that could slow smoke-free growth in high-potential Asian markets. While the company has reaffirmed its 2026 guidance, widening regional prohibitions on non-combustible alternatives force a strategic reliance on established markets like the U.S., Japan, and the European Union.

Shareholder Returns and Deleveraging

Following a strong 2025, management has prioritized capital returns, declaring a quarterly dividend of 1.47 dollars per share, an annualized yield of approximately 3.6%. The company is targeting a net debt to adjusted EBITDA ratio of close to 2.0x by the end of 2026, which may open the door for a resumption of share repurchases in the latter half of the year.